Global Companion Animal Healthcare Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Companion Animal Healthcare Market Research Report 2024
Animal Healthcare refer to the products, which are specially used to prevent and treat animal diseases and ensure animal health, including animal pharmaceuticals and animal vaccines without animal diagnose.
In our report, for vaccine, one unit is 1000 doses.
According to MRAResearch’s new survey, global Companion Animal Healthcare market is projected to reach US$ 17400 million in 2033, increasing from US$ 11950 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Companion Animal Healthcare market research.
Animal Healthcare is widely used for Companion Animal and Farm Animal. The most proportion of Animal Healthcare is used for Companion Animal, and the market share in 2019 is about 53%.
In this report, we study the Animal Healthcare mainly Pharmaceuticals and Vaccines. The most proportion of Animal Healthcare is Pharmaceuticals, and the market share in 2019 is about 66%.
At the same time, also Animal Healthcare mainly oral and injection. The most proportion of Animal Healthcare is injection, and the market share in 2019 is about 66%.
America is the largest consumption place, with a revenue market share nearly 43% in 2019. Following America, Europe is the second largest consumption place with the revenue market share of 19%. Asia Pacific is the region with high growth potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Companion Animal Healthcare market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bayer AG
Merck and Co., Inc
Elanco
Zoetis Inc
Vetoquinol SA
Virbac
Ceva
Perrigo Company plc
Boehringer Ingelheim
Segment by Type
Diagnostics
Therapeutics
Animal Hospital
Animal Clinic
Veterinary Station
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Companion Animal Healthcare report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
In our report, for vaccine, one unit is 1000 doses.
According to MRAResearch’s new survey, global Companion Animal Healthcare market is projected to reach US$ 17400 million in 2033, increasing from US$ 11950 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Companion Animal Healthcare market research.
Animal Healthcare is widely used for Companion Animal and Farm Animal. The most proportion of Animal Healthcare is used for Companion Animal, and the market share in 2019 is about 53%.
In this report, we study the Animal Healthcare mainly Pharmaceuticals and Vaccines. The most proportion of Animal Healthcare is Pharmaceuticals, and the market share in 2019 is about 66%.
At the same time, also Animal Healthcare mainly oral and injection. The most proportion of Animal Healthcare is injection, and the market share in 2019 is about 66%.
America is the largest consumption place, with a revenue market share nearly 43% in 2019. Following America, Europe is the second largest consumption place with the revenue market share of 19%. Asia Pacific is the region with high growth potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Companion Animal Healthcare market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bayer AG
Merck and Co., Inc
Elanco
Zoetis Inc
Vetoquinol SA
Virbac
Ceva
Perrigo Company plc
Boehringer Ingelheim
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Animal Hospital
Animal Clinic
Veterinary Station
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Companion Animal Healthcare report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices